4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0001193125-26-465604
Director sold 10,000 shares at an average $72.67 ($726,678)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
WILSON JAMES N · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-13 | Sale : show line 1 in the form 10b5-1 | −2,191 | $71.80 | $157,316 | 1,052,352 | I |
| 2026-11-13 | Sale : show line 2 in the form 10b5-1 | −7,221 | $72.87 | $526,170 | 1,045,131 | I |
| 2026-11-13 | Sale : show line 3 in the form 10b5-1 | −563 | $73.42 | $41,335 | 1,044,568 | I |
| 2026-11-13 | Sale : show line 4 in the form 10b5-1 | −25 | $74.28 | $1,857 | 1,044,543 | I |
| Open-market sales · 10,000 sh · avg $72.67 · $726,678 | ||||||
Loading xslF345X06/ownership.xml…